3-(Triethoxysilyl)propyl 2-bromo-2-methylpropanoate, 95%, 5g

2,6-Dichloro-N-methylpyridin-4-amine, 95.0%, 5g

1H,1H-Pentafluoropropyl acrylate contains 100 ppm 4-tert-butylcatechol as inhibitor, 97.0%, 5g

3,4-Dimethoxy-1-fluorobenzene, 98.0%, 1g

Methyl 5-bromo-3-hydroxypicolinate, 95.0%, 5g

4-Bromo-1-(bromomethyl)-2-(methylsulfonyl)benzene, 95.0%, 1g

N,N-dimethylaniline, >=99%, for synthesis, 2.5 L, glass packaging

Cyclohexyltrimethoxysilane>97.0%(GC)5g

9-BOC-5-HYDROXY-2,9-DIAZASPIRO[5.5]UNDECANE, 95.0%, 250mg

(3-(Ethylcarbamoyl)-5-nitrophenyl)boronic acid, 98%, 5g

Tri-n-octylsilane, 95%, 25g

1-[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]methanamine, 95.0%, 250mg

1,2,3,5,6,7-Hexahydropyrido[3,2,1-ij]quinoline, 95.0%, 5g